Page last updated: 2024-08-26

carbidopa, levodopa drug combination and cysteine

carbidopa, levodopa drug combination has been researched along with cysteine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Muhlack, S; Müller, T1
Mueller, BK; Muhlack, S; Müller, T; Trommer, I1

Trials

1 trial(s) available for carbidopa, levodopa drug combination and cysteine

ArticleYear
Levodopa increases oxidative stress and repulsive guidance molecule A levels: a pilot study in patients with Parkinson's disease.
    Journal of neural transmission (Vienna, Austria : 1996), 2016, Volume: 123, Issue:4

    Topics: Aged; Antiparkinson Agents; Carbidopa; Chromatography, High Pressure Liquid; Cysteine; Dipeptides; Drug Combinations; Female; GPI-Linked Proteins; Humans; Levodopa; Male; Middle Aged; Nerve Tissue Proteins; Oxidative Stress; Parkinson Disease; Pilot Projects

2016

Other Studies

1 other study(ies) available for carbidopa, levodopa drug combination and cysteine

ArticleYear
Cysteine decrease following acute Levodopa intake in patients with Parkinson's disease.
    Neuroscience letters, 2012, Jul-11, Volume: 521, Issue:1

    Topics: Administration, Oral; Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Carbidopa; Cysteine; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease

2012